I am a
Home I AM A Search Login

Papers of the Week


Neuropsychiatr Dis Treat


Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study.


Miura I, Watabe K, Sakaguchi R, Okamoto K, Maruyama H
Neuropsychiatr Dis Treat. 2022; 18:2627-2637.
PMID: 36387943.


To evaluate the effectiveness and safety of lurasidone 80 mg/day (versus the 40 mg/day dose) during a 12-week, open-label extension study in patients with an acute exacerbation of schizophrenia who had completed a 6-week double-blind study of lurasidone.